67 related articles for article (PubMed ID: 25875016)
1. Anti-inflammatory effect of fullerene C60 in a mice model of atopic dermatitis.
Shershakova N; Baraboshkina E; Andreev S; Purgina D; Struchkova I; Kamyshnikov O; Nikonova A; Khaitov M
J Nanobiotechnology; 2016 Jan; 14():8. PubMed ID: 26810232
[TBL] [Abstract][Full Text] [Related]
2. Structure and biological activity of particles produced from highly activated carbon adsorbent.
Sarnatskaya V; Shlapa Y; Lykhova A; Brieieva O; Prokopenko I; Sidorenko A; Solopan S; Kolesnik D; Belous A; Nikolaev V
Heliyon; 2022 Mar; 8(3):e09163. PubMed ID: 35846471
[TBL] [Abstract][Full Text] [Related]
3. Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice.
Rezende BM; Bernardes PTT; Gonçalves WA; de Resende CB; Athayde RM; Ávila TV; Martins DG; Castor MGM; Teixeira MM; Pinho V
J Immunol Res; 2019; 2019():9015292. PubMed ID: 31781685
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.
Rezende BM; Athayde RM; Gonçalves WA; Resende CB; Teles de Tolêdo Bernardes P; Perez DA; Esper L; Reis AC; Rachid MA; Castor MGME; Cunha TM; Machado FS; Teixeira MM; Pinho V
J Exp Med; 2017 Nov; 214(11):3399-3415. PubMed ID: 28947611
[TBL] [Abstract][Full Text] [Related]
5. The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.
Yang YG; Sykes M
Leuk Lymphoma; 1999 May; 33(5-6):409-20. PubMed ID: 10342569
[TBL] [Abstract][Full Text] [Related]
6. Insights into the pathogenesis of GvHD: what mice can teach us about man.
Hülsdünker J; Zeiser R
Tissue Antigens; 2015 Jan; 85(1):2-9. PubMed ID: 25532439
[TBL] [Abstract][Full Text] [Related]
7. Nanocomposite treatment reduces disease and lethality in a murine model of acute graft-versus-host disease and preserves anti-tumor effects.
Bernardes PT; Rezende BM; Resende CB; De Paula TP; Reis AC; Gonçalves WA; Vieira EG; Pinheiro MV; Souza DG; Castor MG; Teixeira MM; Pinho V
PLoS One; 2015; 10(4):e0123004. PubMed ID: 25875016
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and antioxidant effects of the nanocomposite Fullerol decrease the severity of intestinal inflammation induced by gut ischemia and reperfusion.
Arifa RDN; de Paula TP; Lima RL; Brito CB; Andrade MER; Cardoso VN; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Fagundes CT; Souza DG
Eur J Pharmacol; 2021 May; 898():173984. PubMed ID: 33647256
[TBL] [Abstract][Full Text] [Related]
9. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.
Cooke KR; Gerbitz A; Crawford JM; Teshima T; Hill GR; Tesolin A; Rossignol DP; Ferrara JL
J Clin Invest; 2001 Jun; 107(12):1581-9. PubMed ID: 11413166
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor receptor plays a role in the pathogenesis of graft-versus-host disease by regulating leukocyte recruitment, tissue injury, and lethality.
Castor MG; Rezende BM; Resende CB; Bernardes PT; Cisalpino D; Vieira AT; Souza DG; Silva TA; Teixeira MM; Pinho V
J Leukoc Biol; 2012 Apr; 91(4):629-39. PubMed ID: 22301794
[TBL] [Abstract][Full Text] [Related]
11. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
12. The CCL3/macrophage inflammatory protein-1alpha-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus-leukemia in mice.
Castor MG; Rezende B; Resende CB; Alessandri AL; Fagundes CT; Sousa LP; Arantes RM; Souza DG; Silva TA; Proudfoot AE; Teixeira MM; Pinho V
J Immunol; 2010 Mar; 184(5):2646-54. PubMed ID: 20100934
[TBL] [Abstract][Full Text] [Related]
13. Lithothamnion muelleri controls inflammatory responses, target organ injury and lethality associated with graft-versus-host disease in mice.
Rezende BM; Bernardes PT; Resende CB; Arantes RM; Souza DG; Braga FC; Castor MG; Teixeira MM; Pinho V
Mar Drugs; 2013 Jul; 11(7):2595-615. PubMed ID: 23873335
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
